NO20043569L - Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre - Google Patents
Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyreInfo
- Publication number
- NO20043569L NO20043569L NO20043569A NO20043569A NO20043569L NO 20043569 L NO20043569 L NO 20043569L NO 20043569 A NO20043569 A NO 20043569A NO 20043569 A NO20043569 A NO 20043569A NO 20043569 L NO20043569 L NO 20043569L
- Authority
- NO
- Norway
- Prior art keywords
- metabolites
- sulfonyl
- phenoxy
- pyridine
- tert
- Prior art date
Links
- 125000003352 4-tert-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 239000002207 metabolite Substances 0.000 title 1
- -1 pyridine-3-sulfonyl Chemical group 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35374802P | 2002-01-31 | 2002-01-31 | |
| PCT/IB2003/000121 WO2003064391A1 (fr) | 2002-01-31 | 2003-01-20 | Metabolites d'acide (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20043569L true NO20043569L (no) | 2004-08-26 |
| NO20043569D0 NO20043569D0 (no) | 2004-08-26 |
Family
ID=27663249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043569A NO20043569D0 (no) | 2002-01-31 | 2004-08-26 | Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6852863B2 (fr) |
| EP (1) | EP1470109A1 (fr) |
| JP (1) | JP2005521668A (fr) |
| KR (1) | KR20040077884A (fr) |
| CN (1) | CN1625549A (fr) |
| AP (1) | AP2004003094A0 (fr) |
| AR (1) | AR038332A1 (fr) |
| BR (1) | BR0307339A (fr) |
| CA (1) | CA2473984A1 (fr) |
| EA (1) | EA200400724A1 (fr) |
| EC (1) | ECSP045215A (fr) |
| GB (1) | GB2400100B (fr) |
| HN (1) | HN2003000051A (fr) |
| HR (1) | HRP20040683A2 (fr) |
| HU (1) | HUP0500012A2 (fr) |
| IL (1) | IL162167A0 (fr) |
| IS (1) | IS7281A (fr) |
| MA (1) | MA27169A1 (fr) |
| MX (1) | MXPA04004960A (fr) |
| NO (1) | NO20043569D0 (fr) |
| OA (1) | OA12760A (fr) |
| PA (1) | PA8564601A1 (fr) |
| PE (1) | PE20030978A1 (fr) |
| PL (1) | PL371982A1 (fr) |
| TN (1) | TNSN04138A1 (fr) |
| TW (1) | TW200302080A (fr) |
| UY (1) | UY27632A1 (fr) |
| WO (1) | WO2003064391A1 (fr) |
| ZA (1) | ZA200404067B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| US7666330B2 (en) * | 2005-04-20 | 2010-02-23 | Lg Chem, Ltd. | Additive for non-aqueous electrolyte and secondary battery using the same |
| MX2009001062A (es) * | 2006-07-28 | 2009-02-06 | Pfizer Prod Inc | Agonistas de ep2. |
| AU2008226947B2 (en) | 2007-03-08 | 2014-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| EP2002834A1 (fr) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryle/hétarylamides en tant que modulateurs du récepteur EP2 |
| PT2264009T (pt) * | 2008-03-12 | 2019-04-29 | Ube Industries | Composto do ácido piridilaminoacético |
| EP2149554A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolylamides en tant que modulateurs du récepteur EP2 |
| EP2149551A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | Dérivés de N-(indol-3-ylalkyl)-(hétéro)arylamide en tant que modulateurs du récepteur EP2 |
| EP2149552A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | Dérivés de benzamide 5,6 substitués en tant que modulateurs du récepteur EP2 |
| EP2337563B1 (fr) * | 2008-09-08 | 2014-04-09 | The Board of Trustees of The Leland Stanford Junior University | Modulateurs de l'activité de l'aldéhyde déshydrogénase et leurs procédés d'utilisation |
| JP2012506856A (ja) | 2008-10-28 | 2012-03-22 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法 |
| EP2415763B1 (fr) | 2009-03-30 | 2016-01-27 | Ube Industries, Ltd. | Composition pharmaceutique pour la prévention ou le traitement du glaucome |
| DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
| WO2012149106A1 (fr) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes |
| TW201326154A (zh) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ｅｐ２受體拮抗劑之新穎２ｈ－吲唑 |
| CN105358531B (zh) | 2013-03-14 | 2017-11-14 | 利兰-斯坦福大学初级学院的董事会 | 线粒体醛脱氢酶‑2调节剂和其使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
-
2003
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 CN CNA038029952A patent/CN1625549A/zh active Pending
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/pt not_active IP Right Cessation
- 2003-01-20 IL IL16216703A patent/IL162167A0/xx unknown
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/ja active Pending
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/ko not_active Application Discontinuation
- 2003-01-20 CA CA002473984A patent/CA2473984A1/fr not_active Abandoned
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/fr active Application Filing
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 EA EA200400724A patent/EA200400724A1/ru unknown
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-20 EP EP03700072A patent/EP1470109A1/fr not_active Withdrawn
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/hu unknown
- 2003-01-20 PL PL03371982A patent/PL371982A1/xx not_active Application Discontinuation
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/es unknown
- 2003-01-24 TW TW092101619A patent/TW200302080A/zh unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/es not_active Application Discontinuation
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/es unknown
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-29 AR ARP030100254A patent/AR038332A1/es unknown
- 2003-01-30 UY UY27632A patent/UY27632A1/es not_active Application Discontinuation
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/es unknown
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/is unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/fr unknown
- 2004-07-23 HR HR20040683A patent/HRP20040683A2/hr not_active Application Discontinuation
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/fr unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/es unknown
- 2004-08-26 NO NO20043569A patent/NO20043569D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| OA12760A (en) | 2006-07-04 |
| EA200400724A1 (ru) | 2004-12-30 |
| KR20040077884A (ko) | 2004-09-07 |
| WO2003064391A1 (fr) | 2003-08-07 |
| PL371982A1 (en) | 2005-07-11 |
| TW200302080A (en) | 2003-08-01 |
| UY27632A1 (es) | 2003-08-29 |
| IS7281A (is) | 2004-05-21 |
| JP2005521668A (ja) | 2005-07-21 |
| PA8564601A1 (es) | 2003-09-05 |
| EP1470109A1 (fr) | 2004-10-27 |
| AP2004003094A0 (en) | 2004-09-30 |
| IL162167A0 (en) | 2005-11-20 |
| AR038332A1 (es) | 2005-01-12 |
| GB2400100A (en) | 2004-10-06 |
| GB2400100B (en) | 2006-04-12 |
| PE20030978A1 (es) | 2003-11-19 |
| BR0307339A (pt) | 2004-12-07 |
| TNSN04138A1 (fr) | 2007-03-12 |
| HUP0500012A2 (hu) | 2005-04-28 |
| US20030216445A1 (en) | 2003-11-20 |
| HN2003000051A (es) | 2003-09-24 |
| ZA200404067B (en) | 2005-08-29 |
| US6852863B2 (en) | 2005-02-08 |
| MXPA04004960A (es) | 2005-04-08 |
| ECSP045215A (es) | 2004-09-28 |
| CN1625549A (zh) | 2005-06-08 |
| MA27169A1 (fr) | 2005-01-03 |
| GB0413967D0 (en) | 2004-07-28 |
| NO20043569D0 (no) | 2004-08-26 |
| HRP20040683A2 (en) | 2004-10-31 |
| CA2473984A1 (fr) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043569D0 (no) | Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre | |
| NO20050118D0 (no) | Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon | |
| CY2016042I2 (el) | Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων | |
| DE60336251D1 (de) | Identifikation von aufzeichnungsmedien | |
| NO20032645L (no) | Heterocykliske sulfonamidinhibitorer av <beta>- amyloidproduksjonen | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| DK1488790T3 (da) | Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat | |
| HRP20050361A2 (en) | Synthesis of thiophenecarboxylic acid esters for the production of ramelic acid salts | |
| NO20050563L (no) | N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon | |
| NO20043102L (no) | Fjerning av sure gasser | |
| NO20054408D0 (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
| EA200500201A1 (ru) | Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина | |
| HRP20080027T3 (en) | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide | |
| IS8231A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
| JP2007506758A5 (ja) | ４−（１−ベンゾフラン−３−イル−メチリデンアミノオキシ−プロポキシ）−安息香酸誘導体および線溶系の障害、血栓症の治療用のｐａｉ−１阻害剤としての関連化合物 | |
| EE200300343A (et) | Pantoteenhappe võimendatud produktsiooni meetod | |
| IS7808A (is) | Aðferð til nýmyndunar í iðnaði á metýldíester 5-amínó-3-karboxýmetýl-4-sýanó-2-þíófenkarboxýlsýru | |
| DE60216641D1 (de) | Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure | |
| IS8232A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
| CY2011018I1 (el) | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος | |
| NO20023921D0 (no) | Derivater av thiazepinylhydroksamisk syre som inhibitorer av matriks metalloproteinase | |
| DE60323748D1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung | |
| ATE429214T1 (de) | Mikrokapseln für die verzögerte kontrollierte freisetzung von perindopril | |
| IS8225A (is) | 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma | |
| IS7477A (is) | Aðferð við framleiðslu sýrusalts af gemifloxasíni |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |